Expression-Based Diagnosis, Treatment Selection, and Drug Development for Breast Cancer

Expression-Based Diagnosis, Treatment Selection, and Drug Development for Breast Cancer

There is currently no gene expression assay that can assess if premalignant lesions will develop into invasive breast cancer. This study sought to identify biomarkers for selecting patients with a high potential for developing invasive carcinoma in the breast with normal histology, benign lesions, o...

Full description

Bibliographic Details
Main Authors: Qing Ye, Jiajia Wang, Barbara Ducatman, Rebecca A. Raese, Jillian L. Rogers, Ying-Wooi Wan, Chunlin Dong, Lindsay Padden, Elena N. Pugacheva, Yong Qian, Nancy Lan Guo
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:International Journal of Molecular Sciences
Subjects:
atypical ductal hyperplasia (ADH)
atypical ductal hyperplasia with cancer (ADHC)
diagnosis
CRISPR-Cas9/RNAi
immunohistochemistry
triple-negative breast cancer (TNBC)
Online Access:https://www.mdpi.com/1422-0067/24/13/10561

Internet

https://www.mdpi.com/1422-0067/24/13/10561

Similar Items